Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy - Archive ouverte HAL Access content directly
Journal Articles European Journal of Immunology Year : 2010

Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy

(1) , (1) , (1, 2) , (3) , (1, 2) , (1) , (1) , (1)
1
2
3

Abstract

We recently showed that the infusion of tumor infiltrating lymphocytes specific for the MELOE-1 antigen was associated with a prolonged relapse-free survival for HLA-A2 1 melanoma patients who received tumor infiltrating lymphocytes therapy. Here, we characterized the MELOE-1/A2-specific T-cell repertoire in healthy donors and melanoma patients to further support an immunotherapy targeting this epitope. Using tetramer enrichment followed by multicolor staining, we found that MELOE-1-specific T cells were present in the blood of healthy donors and patients at similar frequencies (around 1 in 1 Â 10 5 CD8 1 cells). These cells mainly displayed a naïve phenotype in 4/6 healthy donors and 3/6 patients, whereas high proportions of memory cells were observed in the remaining individuals of both groups. There was a recurrent usage of the Va12.1 chain for 17/18 MELOE-1-specific T-cell clones derived from healthy donors or patients, associated with diverse Vb chains and V(D)J junctional sequences. All clones derived from melanoma patients (9/9) were reactive against the MELOE-1 36-44 peptide and against HLA-A2 1 melanoma cell lines. This study documents the existence of a large TCR repertoire specific for the MELOE-1/A2 epitope and its capacity to give rise to antitumor CTL that supports the development of immunotherapies targeting this epitope.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-02481945 , version 1 (17-02-2020)

Identifiers

Cite

Yann Godet, Juliette Desfrançois, Virginie Vignard, Dirk Schadendorf, Amir Khammari, et al.. Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy. European Journal of Immunology, 2010, 40 (6), pp.1786-1794. ⟨10.1002/eji.200940132⟩. ⟨inserm-02481945⟩
16 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More